Lexaria Bioscience Analyst Ratings
Lexaria Bioscience Analyst Ratings
While ratings are subjective and will change, the latest Lexaria Bioscience (LEXX) rating was a initiated with a price target of $0.00 to $2.00. The current price Lexaria Bioscience (LEXX) is trading at is $0.79, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/21/2023 | 153.16% | Maxim Group | → $2 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 07/21/2023 | 153.16% | Maxim集團 | →$2 | 開始承保 | →購買 |
What is the target price for Lexaria Bioscience (LEXX)?
Lexaria Bioscience(Lexx)的目標價格是多少？
The latest price target for Lexaria Bioscience (NASDAQ: LEXX) was reported by Maxim Group on July 21, 2023. The analyst firm set a price target for $2.00 expecting LEXX to rise to within 12 months (a possible 153.16% upside). 1 analyst firms have reported ratings in the last year.
Maxim Group於2023年7月21日報道了Lexaria Bioscience(納斯達克：Lexx)的最新目標價。這家分析公司將目標價定為2美元，預計Lexx將在12個月內上漲至(可能上漲153.16)。1家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Lexaria Bioscience (LEXX)?
Lexaria Bioscience(Lexx)的最新分析師評級是多少？
The latest analyst rating for Lexaria Bioscience (NASDAQ: LEXX) was provided by Maxim Group, and Lexaria Bioscience initiated their buy rating.
梅克西姆集團提供了對Lexaria Bioscience(納斯達克：LEXX)的最新分析師評級，Lexaria Bioscience啟動了他們的買入評級。
When is the next analyst rating going to be posted or updated for Lexaria Bioscience (LEXX)?
Lexaria Bioscience(Lexx)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lexaria Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lexaria Bioscience was filed on July 21, 2023 so you should expect the next rating to be made available sometime around July 21, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與利康生物的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。對Lexaria Bioscience的上一次評級是在2023年7月21日提交的，所以你應該預計下一次評級將在2024年7月21日左右的某個時候提供。
Is the Analyst Rating Lexaria Bioscience (LEXX) correct?
分析師對Lexaria Bioscience(Lexx)的評級正確嗎？
While ratings are subjective and will change, the latest Lexaria Bioscience (LEXX) rating was a initiated with a price target of $0.00 to $2.00. The current price Lexaria Bioscience (LEXX) is trading at is $0.79, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Lexaria Bioscience(Lexx)評級是以0.00美元至2.00美元的目標價啟動的。Lexaria Bioscience(Lexx)目前的交易價格為0.79美元，在分析師的預測範圍內。
